Ambrx Biopharma AMAM 深 滬
等待開盤 07-18 09:30:00 美东时间
28.00
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 28.00
- 總市值 17.36亿
- 52周最高 28.15
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 6.55
- 委 比 0.00%
- 總股本 6201.00万
- 歷史最高 28.15
- 量 比 0
- 振 幅 0.00%
- 歷史最低 0.38
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Amid NCI Budget Fears, Emerging Oncology Stocks Gain Attention
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, July 8, 2025 /PRNewswire/ -- Equity Insider News Commentary – As cancer rates climb and drug costs c...
07-08 22:25
Oncology Innovation Just Hit a Turning Point -- Here's What to Watch
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 30, 2025 /PRNewswire/ -- USA News Group News Commentary – The oncology landscape is being pulle...
06-30 23:02
The $900 Billion Question: Who Will Deliver the Next Cancer Breakthrough?
USA News Group News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 26, 2025 /PRNewswire/ -- USA News Group News Commentary – With analysts forecasting the global ...
06-26 23:44
Wall Street Eyes Breakout Cancer Therapies Amid Soaring Drug Prices
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 24, 2025 /PRNewswire/ -- Equity Insider News Commentary – Rising rates of cancer are going to c...
06-25 00:52
As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry
Equity Insider News Commentary Issued on behalf of Oncolytics Biotech Inc. VANCOUVER, BC, June 12, 2025 /PRNewswire/ -- Equity Insider News Commentary – The 2025 ASCO Annual Meeting has wrap...
06-12 22:00
Oncolytics names Jared Kelly as CEO
Oncolytics Biotech (NASDAQ:ONCY) has announced the appointment of Jared Kelly as CEO and a member of its Board of Directors. Most recently, he played a central role in orchestrating the sale of Ambrx ...
06-11 19:46
Oncolytics Names Jared Kelly CEO, Wayne Pisano Steps Down After Guiding Immunotherapy Progress
Oncolytics Biotech® Inc. (NASDAQ:ONCY) (TSX:ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the appointment of Jared Kelly as Chief Executive Officer and a
06-11 19:07
B站累计播放量超5600万，“非典型”的《凸变英雄X》为什么受好评？
转自：上观新闻 今年4月，由B站与Aniplex联合出品、李豪凌导演制作的国漫《凸变英雄X》，在B站、crunchyroll以及日本富士电视...
05-02 14:58
原创动画《凸变英雄X》海外受欢迎
转自：上观新闻 由B站与Aniplex联合出品的原创动画《凸变英雄X》刚刚播出三集，就在全球范围内引发了热烈反响。该动画本月初开始在B站、海...
04-28 22:00
B站国创《凸变英雄X》海外获口碑认可，国产动画迎来新高峰
今年年初，国产动画电影《哪吒之魔童闹海》（以下简称《哪吒2》）登顶全球动画票房榜，让中国动画内容在全球市场上大放异彩，也让国内动画产业迎来了一轮新的发展高潮。...
04-28 20:05
